Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Consolidated Net Profit

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-74 Cr₹98 Cr₹142 Cr₹155 Cr₹93 Cr

What is the latest Consolidated Net Profit of INDOCO REMEDIES ?

The latest Consolidated Net Profit ratio of INDOCO REMEDIES is ₹-74 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-74 Cr
Mar2024₹98 Cr
Mar2023₹142 Cr
Mar2022₹155 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of INDOCO REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-74 Cr
Negative
Mar2024 ₹98 Cr
-30.78
Mar2023 ₹142 Cr
-8.11
Mar2022 ₹155 Cr
66.37
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,798.9 Cr -1.2% -4.8% -12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,855.0 Cr 2.4% 7.1% 14.6% Stock Analytics
DIVIS LABORATORIES ₹168,550.0 Cr -0.2% 3.8% 15.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,906.0 Cr 1.8% 10.9% 48.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,632.0 Cr 1% 4% 16.6% Stock Analytics
CIPLA ₹107,427.0 Cr 0.3% -0.9% -6% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-1.2%

-4.8%

-12.5%

SENSEX

-2.9%

-8%

5.3%


You may also like the below Video Courses